ArticleNeuro-oncology2026

Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier, and distribution to tumor cells in HER2+ brain metastasis model systems.

Imran Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.